Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.

[1]  M. Kami,et al.  Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan , 2012, Leukemia.

[2]  Jun Kato,et al.  Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia , 2012, American journal of hematology.

[3]  Y. Hegerfeldt,et al.  Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies , 2011, Bone Marrow Transplantation.

[4]  C. Brunstein.  Umbilical cord blood transplantation for the treatment of hematologic malignancies. , 2011, Cancer control : journal of the Moffitt Cancer Center.

[5]  J. Wagner,et al.  Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  K. Izutsu,et al.  Mycophenolate and Tacrolimus for Graft-Versus-Host Disease Prophylaxis for Elderly After Cord Blood Transplantation: A Matched Pair Comparison With Tacrolimus Alone , 2011, Transplantation.

[7]  J. Wagner,et al.  Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  T. Hibi,et al.  Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  S. Asano,et al.  Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. , 2007, Blood.

[10]  R. Yamazaki,et al.  Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience , 2007, Bone Marrow Transplantation.

[11]  Y. Kodera,et al.  Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation , 2007, Bone Marrow Transplantation.

[12]  Y. Kanda,et al.  Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  M. Vignetti,et al.  Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. , 2005, Blood.

[14]  K. Cornetta,et al.  Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  S. Asano,et al.  Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. , 2004, Blood.

[16]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[17]  J. Kurtzberg,et al.  Unrelated umbilical cord blood transplantation in adult patients. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  Augustin Ferrant,et al.  Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. , 2003, The New England journal of medicine.

[19]  P. Bolufer,et al.  Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. , 2001, Blood.

[20]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[21]  K. Saito,et al.  Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia wit , 2000, International journal of hematology.

[22]  S. Mineishi,et al.  Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity , 1999, Bone Marrow Transplantation.

[23]  B. Smith,et al.  Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia , 1999, Bone Marrow Transplantation.

[24]  S. Asano,et al.  Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony‐stimulating factor preceding allogeneic bone marrow transplantation , 1999, British journal of haematology.

[25]  S. Asano,et al.  Recombinant human granulocyte colony‐stimulating factor (G‐CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard‐risk myeloid leukemia , 1998, American journal of hematology.

[26]  M. R. Ricciardi,et al.  Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen. , 1995, Cytokines and molecular therapy.

[27]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[28]  P. Thall,et al.  Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  K. Ikebuchi,et al.  Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. , 1994, Bone marrow transplantation.

[30]  K. Saito,et al.  Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors. , 1992, International journal of hematology.

[31]  E. McCulloch,et al.  Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. , 1989, Blood.

[32]  F. Appelbaum,et al.  Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy. , 1988, Bone marrow transplantation.

[33]  R. Storb,et al.  High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Trigg,et al.  Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation , 1987, Cancer.

[35]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.